跳至主要内容
临床试验/ACTRN12622001157763
ACTRN12622001157763尚未招募未知

Safety and Efficacy of Genicular artery embolisation and the effect on knee osteoarthritis - a randomised controlled trial.

South Western Sydney Local health District0 个研究点目标入组 54 人开始时间: 2022年8月24日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
41 Years 至 o limit(—)
性别
All

入选标准

  • >40 years of age.
  • Grade 2 and 3 knee Osteoarthritis on plain radiographs (Kellgren-lawrence scale).
  • Knee pain for 6 months or more, moderate to severe knee pain (VAS >50mm).
  • Pain refractory to conservative management for at least 3 months.
  • Patients capable of consenting for the trial.

排除标准

  • Current local infection.
  • Life expectancy is less than 6 months.
  • Active malignancy.
  • Grade 1 or 4 knee OA on x-rays as per Kellgren-Lawrence Grading scale.
  • Known advanced atherosclerosis in lower limb.
  • Rheumatoid or infectious arthritis.
  • Prior ipsilateral knee surgery excluding arthroscopic surgery more than three months ago.
  • Uncorrectable coagulopathy greater with INR greater than 1.5 (APTT will not be taken).
  • Renal dysfunction as defined by eGFR <45 within the last 60 days.
  • Contraindications for MR imaging.
  • Known history of allergy to contrast media.
  • Women who are lactating, pregnant or trying to become pregnant.
  • Patients with a history of psychological illness, especially severe depression.

研究者

相似试验